PatientFi Expands Partnership with Allergan Aesthetics
The PatientFi-Allergan co-marketing agreement provides financing options for patients interested in treatments including Botox, fillers, breast implants, CoolSculpting, and DiamondGlow.
The PatientFi-Allergan co-marketing agreement provides financing options for patients interested in treatments including Botox, fillers, breast implants, CoolSculpting, and DiamondGlow.
Two new clinical analyses examine how simultaneous, on-label 64-unit onabotulinumtoxinA treatment of the upper face delivers natural-looking, durable, and predictable outcomes across diverse patient populations and multiple treatment cycles.
Researchers found participation among underrepresented racial and ethnic groups increased far beyond national population growth.
Allergan Aesthetics announces the 20 women entrepreneurs who will receive funding and mentorship through the BOTOX Cosmetic and IFundWomen grant program, which aims to support women-owned businesses and address the so-called “confidence gap” in translating ideas into successful ventures.
Read MoreThe Aesthetic Society has released four new episodes of their docuseries ‘Beyond the Before & After,’ which showcases the personal journeys of real patients who have undergone aesthetic plastic surgery and how it has transformed their lives both physically and emotionally.
Read MoreAllergan Aesthetics announces the U.S. FDA approval of Juvéderm Volux XC for the improvement of jawline definition in adults over the age of 21 with moderate to severe loss of jawline definition.
Read MoreCommissioned by Allergan Aesthetics, “The Future of Aesthetics” report aims to help the industry understand the developments driving today’s aesthetics market, and to highlight the key trends that may shape it in the years ahead.
Read MoreAllergan Aesthetics is celebrating Botox’s 20th anniversary as an FDA-approved product with a cross-country art installation.
Read More